What it sells
Natural hydrogel to keep internal organs scar-free after surgery
Business model breakdown
Buyer: who owns the budget?
UnverifiedOrthopedic/hand surgeons and the practices or hospitals that stock surgical supplies (surgeon-facing product).
Trigger: what makes them buy now?
Up to 40% of tendon repair patients face lifelong mobility limits from scar formation; surgeons want better post-operative mobility outcomes.
Workflow: what inputs become what output?
Surgeon mixes and applies blue ECM-based B3 GEL with a proprietary delivery system around the repaired tendon during surgery; gel separates tissue for 1-4 weeks then degrades.
Economics: what it saves and how it charges
UnverifiedPer-procedure single-use gel and delivery system sold to surgical sites (inferred); site cites about 110k US tendon procedures per year as the market.
Distribution: how it reaches customers
UnverifiedContact-led sales to surgeons ("bring the B3 GEL System to your practice"); Contact page only, no online ordering.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2022 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.